Reuters logo
BRIEF-3Sbio Inc enters distribution and promotion agreement with two subsidiaries of Eli Lilly
May 16, 2017 / 12:04 PM / 6 months ago

BRIEF-3Sbio Inc enters distribution and promotion agreement with two subsidiaries of Eli Lilly

May 16 (Reuters) - 3sbio Inc

* Enters distribution and promotion agreement with two subsidiaries of Eli Lilly and co for distribution and promotion of insulin products

* Co has been granted exclusive right of distribution and promotion of Humulin, an insulin product of Lilly, in China from July 1, 2017

* 3Sbio will establish a marketing and promotion team which will cover a wide array of diabetes products, including Humulin Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below